Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Histologically Confirmed Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00128635
What this trial is testing

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine 22
Early research (Phase 1)Study completedNCT00328458
What this trial is testing

EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients

Who this might be right for
Central Nervous System NeoplasmsHead and Neck Neoplasms
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Large-scale testing (Phase 3)Ended earlyNCT00412776
What this trial is testing

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more
Sesen Bio, Inc. 165
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableStudy completedNCT00588198
What this trial is testing

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 754
Early research (Phase 1)Study completedNCT00923182
What this trial is testing

A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Genzyme, a Sanofi Company 6
Large-scale testing (Phase 3)Study completedNCT03849118
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 300
Testing effectiveness (Phase 2)Study completedNCT00753714
What this trial is testing

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 124
Testing effectiveness (Phase 2)Ended earlyNCT01601184
What this trial is testing

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Who this might be right for
Histologically Confirmed MedulloblastomaActivation of the Sonic Hedgehog (SHH) Pathway
Centre Leon Berard 24
Large-scale testing (Phase 3)Study completedNCT05445167
What this trial is testing

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Who this might be right for
Uterine Fibroids (MeSH Heading: Leiomyoma)
Kissei Pharmaceutical Co., Ltd. 89
Not applicableLooking for participantsNCT06214611
What this trial is testing

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

Who this might be right for
Head and Neck CancerAdaptive RadiotherapyRadiation+3 more
University Hospital, Essen 50
Early research (Phase 1)Study completedNCT00528684
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Oncolytics Biotech 18
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Testing effectiveness (Phase 2)UnknownNCT05902377
What this trial is testing

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking Union Medical College Hospital 46
Not applicableStudy completedNCT01248000
What this trial is testing

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Who this might be right for
Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification
Gruppo Italiano Studio Linfomi 136
Testing effectiveness (Phase 2)Study completedNCT01207388
What this trial is testing

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 116
Post-approval studies (Phase 4)Active Not RecruitingNCT06121401
What this trial is testing

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Who this might be right for
Carcinoma, Ovarian Epithelial
Mario Negri Institute for Pharmacological Research 190
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Not applicableUnknownNCT03043508
What this trial is testing

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

Who this might be right for
Genetic MutationMEN1
M.D. Anderson Cancer Center 45
Early research (Phase 1)Ended earlyNCT00747825
What this trial is testing

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Molecular Insight Pharmaceuticals, Inc. 12
Next Page